LSTA Lisata Therapeutics, Inc.

NASDAQ
$1.58

Lisata Therapeutics, Inc. (LSTA) SEC Filings

Everything LSTA has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

11 filings
Date Form Filing
8-K Acquisition Disposition · Capital Raise · Dilution · Executive Change · Governance Change · Investor Presentation · Material Agreement · Reg Fd
SCHEDULE 13G
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.